全文获取类型
收费全文 | 32891篇 |
免费 | 2673篇 |
国内免费 | 1303篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 554篇 |
妇产科学 | 258篇 |
基础医学 | 1925篇 |
口腔科学 | 1266篇 |
临床医学 | 2615篇 |
内科学 | 3304篇 |
皮肤病学 | 298篇 |
神经病学 | 1176篇 |
特种医学 | 743篇 |
外国民族医学 | 8篇 |
外科学 | 1893篇 |
综合类 | 4824篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 3906篇 |
眼科学 | 480篇 |
药学 | 6715篇 |
12篇 | |
中国医学 | 4611篇 |
肿瘤学 | 2140篇 |
出版年
2024年 | 110篇 |
2023年 | 558篇 |
2022年 | 1207篇 |
2021年 | 1484篇 |
2020年 | 1276篇 |
2019年 | 1390篇 |
2018年 | 1305篇 |
2017年 | 1379篇 |
2016年 | 1320篇 |
2015年 | 1167篇 |
2014年 | 2063篇 |
2013年 | 2706篇 |
2012年 | 2023篇 |
2011年 | 2136篇 |
2010年 | 1683篇 |
2009年 | 1516篇 |
2008年 | 1462篇 |
2007年 | 1521篇 |
2006年 | 1260篇 |
2005年 | 1139篇 |
2004年 | 974篇 |
2003年 | 932篇 |
2002年 | 705篇 |
2001年 | 611篇 |
2000年 | 525篇 |
1999年 | 471篇 |
1998年 | 365篇 |
1997年 | 389篇 |
1996年 | 344篇 |
1995年 | 290篇 |
1994年 | 263篇 |
1993年 | 231篇 |
1992年 | 224篇 |
1991年 | 168篇 |
1990年 | 157篇 |
1989年 | 138篇 |
1988年 | 164篇 |
1987年 | 107篇 |
1986年 | 83篇 |
1985年 | 178篇 |
1984年 | 149篇 |
1983年 | 134篇 |
1982年 | 112篇 |
1981年 | 75篇 |
1980年 | 80篇 |
1979年 | 51篇 |
1978年 | 52篇 |
1977年 | 28篇 |
1976年 | 47篇 |
1975年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
《Clinical genitourinary cancer》2022,20(5):442-451
IntroductionSelective internal radiation therapy (SIRT) is a potential treatment of primary renal cell carcinoma (RCC) deemed unsuitable for conventional therapy. RESIRT is the first-in-human study to evaluate safety and feasibility of SIRT for primary RCC.Patients and MethodsPatients with RCC, unsuitable for, or who declined conventional therapy, were eligible. A single transfemoral micro-catheter administration of yttrium-90 (Y-90) resin microspheres (SIR-Spheres) was delivered super selectively via the renal artery to the tumour at intended radiation doses of 75, 100, 150, 200, 300 Gy and a final cohort with a procedural endpoint of “imminent stasis,” in a dose-escalation design. Post-SIRT follow-up was 12 months. Study endpoints included safety and toxicity 30-days and 12-months post-SIRT and tumour response (RECIST v1.1).ResultsIn total, 21 patients were enrolled, mean (SD) age was 75 (9.3) years, WHO performance status was 0 in 81%, 12 (57%) had stage 3 chronic kidney disease, and 7 (33%) had prior contralateral nephrectomy. Overall, 71% of patients completed 12 months of follow-up. Intended doses were delivered without any dose-limiting toxicity. Seventeen out of 21 (81%) patients experienced an adverse event (AE) from any cause within 30 days post-SIRT; all SIRT-related AEs were grade 1 to 2. Best overall tumour responses were partial response 1/21 (4.8%), stable disease 19/21 (90.5%) and progressive disease 1/21 (4.8%).ConclusionThis study demonstrated good tolerability of SIRT at all dose levels including “imminent stasis” in treating primary tumours in RCC patients otherwise unsuitable for conventional therapy. SIRT with Y-90 resin microspheres may be a feasible treatment option for RCC. 相似文献
3.
4.
Ariel Paracampo Marina Solis Carlos Bonetto 《International journal of environmental health research》2015,25(1):96-103
Chlorpyrifos is the most used insecticide in Argentina. Cnesterodon decemmaculatus is a widely distributed, endemic fish from Neotropical America. It attains high densities in the shallow water assemblages of Argentina and Brazil. The aim of this study was to assess the acute toxicity of chlorpyrifos to C. decemmaculatus. The mean 96-h LC50 of three independent determinations was 105.3 (±?3.1) μg/L. Sublethal effects were observed. Swimming behavioral changes at each chlorpyrifos exposure concentration were reported. C. decemmaculatus represents a good model for ecotoxicological risk assessment. 相似文献
5.
6.
中风病是临床的常见病、多发病。本病病因较多,病情变化迅速,证型繁杂,不同的文献中证候分类差异较大。证候分类的繁杂给临床工作者治疗中风病带来极大不便。本文对以证候要素(内风、内火、痰湿、瘀血、气虚、阴虚)为切入点论治中风病的理论进行探讨,并举例论证其临床疗效。 相似文献
7.
8.
Rapid industrial and technological development has impacted ecosystem homeostasis strongly. Arsenic is one of the most detrimental environmental toxins and its management with chelating agents remains a matter of concern due to associated adverse effects. Thus, safer and more effective alternative therapy is required to manage arsenic toxicity. Based on existing evidence, native and indigenous plant-based active biomolecules appear as a promising strategy to mitigate arsenic-induced toxicity with an acceptable safety profile. In this regard, various phytochemicals (flavonoids and stilbenoids) are considered important classes of polyphenolic compounds with antioxidant and chelation effects, which may facilitate the removal of arsenic from the body more effectively and safely with regard to conventional approaches. This review presents an overview of conventional chelating agents and the potential role of flavonoids and stilbenoids in ameliorating arsenic toxicity. This report may provide a roadmap for identifying novel prophylactic/therapeutic strategies for managing arsenic toxicity. 相似文献
9.
经脉包括经(气)络和血(脉)络,清代周学海《读医随笔》将气络末端称为"气之细络",脉络末端称为"血之细络"。心之气络涵盖心脏起搏与传导系统等广泛调控机制,心之脉络涵盖冠状动脉循环系统,心之气络与脉络相互协调,营卫相偕而行,共同维持心脏正常功能。各种致病因素导致营卫异常而发为心律失常,基于脉络学说营卫理论"损其心者,调其营卫"(《难经·十四难》)治疗原则指导心律失常辨证论治,同时充分结合现代致病因素和致病特点,分别选用调节卫气营血之方药,标本兼治,以期为临床诊疗提供有益借鉴。 相似文献
10.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(10):653-669
AimsPatient factors affect the risk of radiotherapy toxicity, but many are poorly defined. Studies have shown that race affects cancer incidence, survival, drug response, molecular pathways and epigenetics. Effects on radiosensitivity and radiotherapy toxicity are not well studied. The aim of the present study was to identify the effects of race and ethnicity on the risk of radiotherapy toxicity.Materials and methodsA systematic review was carried out of PubMed, Ovid Medline and Ovid Embase with no year limit. PRISMA 2020 guidelines were followed. Two independent assessors reviewed papers.ResultsOf 607 papers screened, 46 fulfilled the inclusion criteria. Papers were published between 1996 and 2021 and involved 30–28,354 individuals (median 433). Most involved patients with prostate (33%), breast (26%) and lung (9%) cancer. Both early and late toxicities were studied. Some studies reported a higher risk of toxicity in White men with prostate cancer compared with other races and ethnicities. For breast cancer patients, some reported an increased risk of toxicity in White women compared with other race and ethnic groups. In general, it was difficult to draw conclusions due to insufficient reporting and analysis of race and ethnicity in published literature.ConclusionsReporting of race and ethnicity in radiotherapy studies must be harmonised and improved and frameworks are needed to improve the quality of reporting. Further research is needed to understand how ancestral heritage might affect radiosensitivity and risk of radiotherapy toxicity. 相似文献